Hartmut Häntze

Hartmut Häntze

Auto-generated profile, based on publicly available information

Hartmut Häntze

Department of Medical Imaging, Radboudumc, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
HHHartmut Häntze
Hartmut Häntze
LXLina Xu
Lina Xu
CMChristian J. Mertens
Christian J. Mertens
FDFelix J. Dorfner
Felix J. Dorfner
LDLeonhard Donle
Leonhard Donle
KBKeno Bressem
Keno Bressem
MRSegmentator accurately segmented 40 anatomic structures on MRI and CT across three external datasets.

1 June 2023 in Bioinformatics
Verified
Journal Article
Open access
PDF file
HHHartmut Häntze
Hartmut Häntze
PHPaul Horton
Paul Horton
Motivation: Alignment-free, k-mer based genotyping methods are a fast alternative to alignment-based methods and are particularly well suited for genotyping larger cohorts. The sensitivity of algorithms, that work with k-mers, can be increased by using spaced seeds, however, the application of spaced seeds in k-mer based genotyping methods has not been researched yet. Results: We add a spaced seeds functionality to the genotyping software PanGenie and use it to calculate genotypes. This significantly improves sensitivity and F-score when genotyping SNPs, indels, and structural variants on reads with low (5×) and high (30×) coverage. Improvements are greater than what could be achieved by just increasing the length of contiguous k-mers. Effect sizes are particularly large for low coverage data. If applications implement effective algorithms for hashing of spaced k-mers, spaced k-mers have the potential to become an useful technique in k-mer based genotyping. Availability and implementation: The source code of our proposed tool MaskedPanGenie is openly available on https://github.com/hhaentze/MaskedPangenie.

14 May 2025 in The Lancet Regional Health - Europe
Verified
Journal Article
Open access
SZSebastian Ziegelmayer
Sebastian Ziegelmayer
HHHartmut Häntze
Hartmut Häntze
CMChristian Mertens
Christian Mertens
FBFelix Busch
Felix Busch
TLTristan Lemke
Tristan Lemke
KBKeno Bressem
Keno Bressem
Chronic back pain (CBP) affects over 80 million people in Europe, contributing to substantial healthcare costs and disability. Understanding modifiable risk factors, such as muscle composition, may aid in prevention and treatment. This study investigates the association between lean muscle mass (LMM) and intermuscular adipose tissue (InterMAT) with CBP using noninvasive whole-body magnetic resonance imaging (MRI). This cross-sectional analysis used whole-body MRI data from 30,868 participants in the German National Cohort (NAKO), collected between 1 May 2014 and 1 September 2019. CBP was defined as back pain persisting >3 months. LMM and InterMAT were quantified via MRI-based muscle segmentations using a validated deep learning model. Associations were analyzed using mixed logistic regression, adjusting for age, sex, diabetes, dyslipidemia, osteoporosis, osteoarthritis, physical activity, and study site. Among 27,518 participants (n = 12,193/44.3% female, n = 14,605/55.7% male; median age 49 years IQR 41; 57), 21.8% (n = 6003; n = 2999/50.0% female, n = 3004/50% male; median age 53 years IQR 46; 60) reported CBP, compared to 78.2% (n = 21,515; n = 9194/42.7% female, n = 12,321/57.3% male; median age 48 years IQR 39; 56) who did not. CBP prevalence was highest in those with low (5000 MET min/week) self-reported physical activity levels (24.6% (n = 10,892) and 22.0% (n = 3800), respectively) compared to moderate (500–5000 MET min/week) levels (19.4% (n = 12,826); p < 0.0001). Adjusted analyses revealed that a higher InterMAT (OR 1.22 per 2-unit Z-score; 95% CI 1.13–1.30; p < 0.0001) was associated with an increased likelihood of chronic back pain (CBP), whereas higher lean muscle mass (LMM) (OR 0.87 per 2-unit Z-score; 95% CI 0.79–0.95; p = 0.003) was associated with a reduced likelihood of CBP. Stratified analyses confirmed these associations persisted in individuals with osteoarthritis (OA-CBP LMM: 22.9 cm3/kg/m; InterMAT: 7.53% vs OA-No CBP LMM: 24.3 cm3/kg/m; InterMAT: 6.96% both p < 0.0001) and osteoporosis (OP-CBP LMM: 20.9 cm3/kg/m; InterMAT: 8.43% vs OP-No CBP LMM: 21.3 cm3/kg/m; InterMAT: 7.9% p = 0.16 and p = 0.0019). Higher pain intensity (Pain Intensity Numerical Rating Scale ≥4) correlated with lower LMM (2-unit Z-score deviation = OR, 0.63; 95% CI, 0.57–0.70; p < 0.0001) and higher InterMAT (2-unit Z-score deviation = OR, 1.22; 95% CI, 1.13–1.30; p < 0.0001), independent of physical activity, osteoporosis and osteoarthritis. This large, population-based study highlights the associations of InterMAT and LMM with CBP. Given the limitations of the cross-sectional design, our findings can be seen as an impetus for further causal investigations within a broader, multidisciplinary framework to guide future research toward improved prevention and treatment. The NAKO is funded by the 10.13039/501100002347 Federal Ministry of Education and Research (BMBF) [project funding reference numbers: 01ER1301A/B/C, 01ER1511D, 01ER1801A/B/C/D and 01ER2301A/B/C], federal states of Germany and the 10.13039/501100009318 Helmholtz Association , the participating universities and the institutes of the 10.13039/501100001664 Leibniz Association .

1 May 2026 in Machine Learning for Biomedical Imaging
Verified
Journal Article
Open access
PDF file
SBSarah de Boer
Sarah de Boer
HHHartmut HänTze
Hartmut HänTze
KVKiran Vaidhya Venkadesh
Kiran Vaidhya Venkadesh
MBMyrthe Buser
Myrthe Buser
GMGabriel E. Humpire Mamani
Gabriel E. Humpire Mamani
AHAlessa Hering
Alessa Hering
Renal mass segmentation has important potential to enhance the clinical workflow, especially in settings requiring quantitative assessments. Kidney volume could serve as an important biomarker for renal diseases, with changes in volume correlating directly with kidney function. Currently, clinical practice often relies on subjective visual assessment for evaluating kidney size and kidney lesions, including tumors and cysts, which are typically staged based on diameter, volume, and anatomical location. To support a more objective and reproducible approach, this research aims to develop a robust, thoroughly validated renal mass segmentation algorithm, named Renal-Net. We employ publicly available training datasets and leverage the state-of-the-art medical image segmentation framework nnU-Net. Validation is conducted using both proprietary and public test datasets, with segmentation performance quantified by Dice coefficient and the 95th percentile Hausdorff distance. Furthermore, we analyze robustness across subgroups based on patient sex, age, CT contrast phases, and tumor histologic subtypes. Our findings demonstrate that our segmentation algorithm, trained exclusively on publicly available data, generalizes effectively to external test sets and outperforms existing state-of-the-art models across all tested datasets. Subgroup analyses reveal consistent high performance, indicating strong robustness and reliability. The developed algorithm and associated code are publicly accessible at https://github.com/DIAGNijmegen/oncology-kidney-abnormality-segmentation

23 April 2026 in medRxiv
Verified
Preprint
Open access
PDF file
SBSarah de Boer
Sarah de Boer
HHHartmut Häntze
Hartmut Häntze
SZSebastian Ziegelmayer
Sebastian Ziegelmayer
BGBram van Ginneken
Bram van Ginneken
MPMathias Prokop
Mathias Prokop
AHAlessa Hering
Alessa Hering
Background: Medical imaging, especially computed tomography and magnetic resonance imaging, is essential in clinical care of patients with renal cell carcinoma (RCC). Artificial intelligence (AI) research into computer-aided diagnosis, staging and treatment planning needs curated and annotated datasets. Across literature, The Cancer Genome Atlas (TCGA) datasets are widely used for model training and validation. However, re-annotation is often necessary due to limited access to public annotations, raising entry barriers and hindering comparison with prior work. Methods: We screened 1915 CT scans from three TCGA-RCC databases and employed a segmentation model to annotate kidney lesion. After a meta-data-based exclusion step, we hosted a reader study with all papillary (n=56), chromophobe (n=27) and 200 randomly selected clear cell RCC cases. Two students quality checked and corrected the data as well as annotated tumors and cysts. Uncertain cases were checked by a board-certified radiologist. Results: After data exclusion and quality control a total of 142 annotated CT scans from 101 patients (26 female, 75 male, mean age 56 years) remained. This includes 95 CTs with clear cell RCC, 29 with papillary RCC and 18 with chromophobe RCC. Images and voxel-level annotations of kidneys and lesions are open sourced at https://zenodo.org/records/19630298 . Conclusion: By making the annotations open-source, we encourage accessible and reproducible AI research for renal cell carcinoma. We invite other researchers who have previously annotated any of these cohorts to share their annotations.

1 May 2026 in Radiology
Verified
Journal Article
Closed access
SZSebastian Ziegelmayer
Sebastian Ziegelmayer
HHHartmut Häntze
Hartmut Häntze
CMChristian Mertens
Christian Mertens
FBFelix Busch
Felix Busch
TLTristan Lemke
Tristan Lemke
KBKeno Bressem
Keno Bressem
Artificial intelligence–derived muscle composition from whole-body MRI scans identified individuals with cardiometabolic risk factors but no pre-existing conditions in a nationwide population.